A detailed history of Veery Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Veery Capital, LLC holds 1,652 shares of DHR stock, worth $392,647. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,652
Previous 1,622 1.85%
Holding current value
$392,647
Previous $405,000 13.33%
% of portfolio
0.17%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$239.25 - $280.76 $7,177 - $8,422
30 Added 1.85%
1,652 $459,000
Q2 2024

Jul 18, 2024

BUY
$235.51 - $267.98 $4,945 - $5,627
21 Added 1.31%
1,622 $405,000
Q1 2024

Apr 19, 2024

BUY
$224.58 - $256.19 $3,593 - $4,099
16 Added 1.01%
1,601 $399,000
Q4 2023

Jan 10, 2024

SELL
$185.1 - $233.13 $7,218 - $9,092
-39 Reduced 2.4%
1,585 $366,000
Q3 2023

Oct 13, 2023

BUY
$233.08 - $265.59 $14,450 - $16,466
62 Added 3.97%
1,624 $402,000
Q2 2023

Jul 13, 2023

BUY
$224.99 - $256.14 $2,699 - $3,073
12 Added 0.77%
1,562 $374,000
Q1 2023

Apr 13, 2023

SELL
$239.75 - $277.0 $959 - $1,108
-4 Reduced 0.26%
1,550 $390,000
Q4 2022

Jan 17, 2023

SELL
$241.42 - $282.29 $12,071 - $14,114
-50 Reduced 3.12%
1,554 $0
Q2 2022

Jul 18, 2022

SELL
$237.11 - $299.66 $237 - $299
-1 Reduced 0.06%
1,604 $407,000
Q1 2022

Apr 18, 2022

SELL
$257.27 - $315.76 $1,029 - $1,263
-4 Reduced 0.25%
1,605 $471,000
Q4 2021

Jan 13, 2022

SELL
$292.08 - $329.01 $4,089 - $4,606
-14 Reduced 0.86%
1,609 $529,000
Q3 2021

Oct 13, 2021

SELL
$272.21 - $332.43 $816 - $997
-3 Reduced 0.18%
1,623 $494,000
Q1 2021

Apr 28, 2021

SELL
$212.38 - $245.9 $12,318 - $14,262
-58 Reduced 3.44%
1,626 $366,000
Q4 2020

Feb 08, 2021

BUY
$212.5 - $245.46 $357,850 - $413,354
1,684 New
1,684 $374,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Veery Capital, LLC Portfolio

Follow Veery Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veery Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veery Capital, LLC with notifications on news.